| 19-Jul-14 09:12AM | Roundtable: 3 Stocks Janet Yellen Is Dead Wrong About at Motley Fool |
| 17-Jul-14 06:10PM | Your first trade for Friday at CNBC |
| 05:59PM | [video] Fast Money Final Trade: GOOGL, MSFT & more at CNBC |
| 08:12AM | The Zacks Analyst Blog Highlights: AbbVie, Shire, Gilead Sciences, Sarepta Therapeutics and Celgene Zacks |
| 12-Jul-14 06:01PM | 3 Stocks Crushed by the Market This Week at Motley Fool |
| 11-Jul-14 04:33PM | 3 Reasons Not to Worry About Sarepta Therapeutics Inc. at Motley Fool |
| 04:00PM | Sarepta Plunges on Eteplirsen Study Results Zacks |
| 09:49AM | Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT) at TheStreet |
| 08:50AM | Today's Top Biotech Stocks to Watch: Johnson & Johnson and Sarepta Therapeutics at Motley Fool |
| 07:03AM | Sarepta Therapeutics Slumps: SRPT Tanks 12.9% in Session Zacks |
| 10-Jul-14 05:45PM | [video] Stock Pops & Drops: COH, SRPT, CRAY, LB at CNBC -12.94% |
| 04:26PM | Should Sarepta's Shares Be Tumbling? at Motley Fool |
| 03:24PM | Deutsche Bank Questions Long-Term Efficacy Of Sarepta's Eteplirsen Following Trial News Benzinga |
| 02:10PM | Why Sarepta Therapeutics Inc. Stock Collapsed at Motley Fool |
| 01:39PM | Investors Remain Confident in Sarepta After Shares Fall 20 Percent StockTwits |
| 01:28PM | Sarepta price target lowered to $34 from $52 at Roth Capital theflyonthewall.com |
| 12:38PM | Sarepta potential for near-term approval lower after update, says Piper Jaffray theflyonthewall.com |
| 11:52AM | Janney Capital reiterates Sell rating on Sarepta at theflyonthewall.com |
| 11:50AM | Sarepta story correction issued by Wall Street Journal at theflyonthewall.com |
| 11:38AM | Down 17%: Is Sarepta a Bad News Buy? at Motley Fool |
| 10:54AM | Sarepta shares defended at Needham at theflyonthewall.com |
| 10:51AM | Why Sarepta Therapeutics (SRPT) Stock Is Plunging Today at TheStreet |
| 10:09AM | Sarepta shares fall on muscular dystrophy drug data at CNBC |
| 08:47AM | Sarepta Releases New Data, Facing A Sea Change At Regulators at Forbes |
| 08:47AM | Sarepta Data Disappoints Wall Street As Expert Sees A Sea Change At FDA at Forbes |
| 08:47AM | Sarepta Data Disappoints As Expert Sees A Sea Change At FDA at Forbes |
| 08:32AM | Sarepta says on track to initiate several new studies of eteplirsen at theflyonthewall.com |
| 08:31AM | Latest Sarepta Study Update Shows Greater Decline in Walking Ability at TheStreet |
| 08:31AM | [video] Sarepta to file for approval of Eteplirsen at CNBC |
| 08:30AM | Sarepta Therapeutics Reports Long-Term Outcomes Through 144 Weeks from Phase IIb Study of Eteplirsen in Duchenne Muscular Dystrophy Business Wire |
| 08-Jul-14 01:06PM | [video] Rough day for biotech at CNBC -7.29% |
| 07:06AM | Sarepta Therapeutics (SRPT) Enters Oversold Territory Zacks |
| 07-Jul-14 02:49PM | Sarepta's Monday Selloff on New (Old) Worries Addressed at TheStreet -7.36% |
| 27-Jun-14 06:22AM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 06:22AM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders |
| 24-Jun-14 08:10AM | Short Interest is Piling Up in Sarepta Therapeutics (SRPT) Stock, Time to Panic? Zacks |
| 08:10AM | Short Interest is Piling Up in Sarepta Therapeutics (SRPT) Stock, Time to Panic? |
| 18-Jun-14 04:30PM | Sarepta Therapeutics to Present Company Overview at the JMP Securities Healthcare Conference on June 24 Business Wire |
| 04:30PM | Sarepta Therapeutics to Present Company Overview at the JMP Securities Healthcare Conference on June 24 |
| 09-Jun-14 12:59PM | SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sarepta Therapeutics Inc. Regarding Possible Breaches of Fiduciary Duty PR Newswire |
| 12:59PM | SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sarepta Therapeutics Inc. Regarding Possible Breaches of Fiduciary Duty |
| 07-Jun-14 06:33PM | Why Wall Street is Betting Heavily Against Sarepta Therapeutics at Motley Fool |
| 06:33PM | Why Wall Street is Betting Heavily Against Sarepta Therapeutics |
| 06-Jun-14 05:11PM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 05:11PM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders |
| 04-Jun-14 06:02PM | What You Need to Know About PTC Therapeutics' Promising DMD Drug at Motley Fool |
| 06:02PM | What You Need to Know About PTC Therapeutics' Promising DMD Drug |
| 03-Jun-14 09:21AM | Tuesdays Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology at Motley Fool |
| 09:21AM | Tuesdays Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology |
| 07:39AM | Prosensa to Seek U.S. Approval for DMD Drug at TheStreet |
| 07:39AM | Prosensa to Seek U.S. Approval for DMD Drug |
| 02-Jun-14 09:34AM | Sarepta Therapeutics Opens New Global Headquarters in Cambridge, Mass. Business Wire |
| 09:34AM | Sarepta Therapeutics Opens New Global Headquarters in Cambridge, Mass. |
| 31-May-14 11:56PM | Surprising MS Drug Approval: Time to Buy? at Motley Fool |
| 11:56PM | Surprising MS Drug Approval: Time to Buy? |
| 28-May-14 04:32PM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online |
| 04:32PM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 27-May-14 01:12PM | 3 Stocks That Soared Stupendously Last Week at Motley Fool |
| 23-May-14 03:45PM | Sarepta to Acquire Manufacturing Facility Zacks |
| 01:28PM | Isis Pharmaceuticals: 'The Best Pipeline in Biotech,' Potential Takeover Target at Barrons.com |
| 12:37PM | PTC Muscular Dystrophy Drug Wins EU Panel Vote at Investor's Business Daily |
| 12:04PM | PTC Muscular Dystrophy Drug Wins EU Panel Vote at Investor's Business Daily |
| 10:25AM | [video] Ataluren drives PTC Therapeutics at CNBC |
| 08:46AM | PTC Therapeutics Gets Warm Hug From Europe for DMD Drug; Prosensa Rises in Sympathy at TheStreet |
| 07:12AM | [$$] Sarepta Looks Like a First-Mover at Barrons.com |
| 22-May-14 11:36AM | Sarepta gearing for potential 2015 launch of eteplirsen, says Piper Jaffray at theflyonthewall.com |
| 08:56AM | Today's Top Health Care Stocks to Watch: Celgene Corporation and Sarepta Therapeutics, Inc. at Motley Fool |
| 08:32AM | Sarepta announces acquisition of Massachusetts manufacturing facillity at theflyonthewall.com |
| 08:30AM | Sarepta Therapeutics Announces Agreement for Acquisition of Manufacturing Facility in Massachusetts Business Wire |
| 07:07AM | Sarepta initiated with a Buy at Roth Capital at theflyonthewall.com |
| 20-May-14 05:02PM | Sarepta Therapeutics' (SRPT) CEO Presents at UBS Global Healthcare Conference (Transcript) at Seeking Alpha |
| 16-May-14 01:04PM | SAREPTA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 08:30AM | Sarepta Therapeutics to Present Company Overview at the UBS Global Healthcare Conference on May 20 Business Wire |
| 14-May-14 06:17PM | Sarepta Therapeutics' (SRPT) CEO Chris Garabedian Hosts Sarepta DMD Development Program Update (Transcript) at Seeking Alpha |
| 13-May-14 04:24PM | Sarepta Therapeutics' (SRPT) CEO Christopher Garabedian on Bank of America Merrill Lynch Health Care Conference (Transcript) at Seeking Alpha |
| 11:00AM | Sarepta Therapeutics Inc Conference Call to discuss DMD Development Program Update scheduled for 11:00 am ET today CCBN |
| 11:00AM | Electro Scientific Industries, Inc. Earnings Call scheduled for 11:00 am ET today CCBN |
| 07:34AM | Sarepta Therapeutics Inc Conference Call to discuss DMD Development Program Update scheduled for 11:00 am ET today CCBN |
| 12-May-14 12:24PM | Busy Days Ahead for Sarepta Therapeutics at Motley Fool |
| 10-May-14 06:02PM | Sarepta Therapeutics's (SRPT) CEO Chris Garabedian Presents at Deutsche Bank Healthcare Conference (Transcript) at Seeking Alpha |
| 09-May-14 03:03PM | Sarepta to hold a conference call at theflyonthewall.com |
| 06:00AM | Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack at TheStreet |
| 08-May-14 12:37PM | Sarepta Therapeutics' (SRPT) CEO Chris Garabedian on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha -9.28% |
| 11:48AM | Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing at Motley Fool |
| 08:00AM | Sarepta Therapeutics Inc. Earnings Call scheduled for 8:00 am ET today CCBN |
| 07:19AM | SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 07:07AM | Sarepta reports Q1 EPS (55c) ex-items, consensus (80c) at theflyonthewall.com |
| 07:07AM | Q1 2014 Sarepta Therapeutics Inc Earnings Release - Before Market Open CCBN |
| 07:00AM | Sarepta Therapeutics Announces First Quarter 2014 Financial Results and Recent Corporate Developments Business Wire |
| 06:56AM | SAREPTA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07-May-14 11:25AM | Why I Have Re-Entered Sarepta Therapeutics at Seeking Alpha |
| 06-May-14 08:30AM | Sarepta Therapeutics to Present Company Overview at the 2014 Bank of America Merrill Lynch Healthcare Conference Business Wire |
| 05-May-14 06:20PM | Biotech 101: Valuing Binary Events at Motley Fool |
| 02-May-14 07:26AM | A Wall Street Transcript Interview with Brian Skorney, a Senior Analyst with Robert W. Baird & Co. Covering Biotechnology: Biotech Capital Inflows Reach Historic Highs Wall Street Transcript |
| 29-Apr-14 08:35AM | Sarepta Therapeutics to Present Company Overview at the 2014 39th Annual Deutsche Bank Healthcare Conference Business Wire |
| 08:30AM | Sarepta Therapeutics to Announce First Quarter 2014 Financial Results and Corporate Update on May 8, 2014 Business Wire |
| 28-Apr-14 03:18PM | Cancer and Hepatitis C Treatment Breakthroughs Boost Pharma Stocks: Citigroup Investment Global Head of Healthcare Research & Analysis Andrew Baum, M.D. Interviews with the Wall Street Transcript Wall Street Transcript |
| 08:30AM | Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on May 13, 2014 Business Wire |
| 26-Apr-14 07:31AM | 3 Stocks That Soared Stupendously This Week at Motley Fool |
| 01:42AM | [$$] Why Apple Shares Could Keep Climbing at Barrons.com |
